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plethora of inﬂammatory cytokines have been11
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116Aimplicated in various gastrointestinal (GI) tract
disorders, but there still is limited knowledge regarding the
mechanisms underlying the interaction between epithelial
and immune cells that lead to major disturbances in GI
mucosa homeostasis.
In this issue of Cellular and Molecular Gastroenterology
and Hepatology, Jarry et al1 showed that one of the type I
interferons, interferon a (IFN-a), induces apoptosis and
promotes intestinal epithelial barrier disruption by activating
the inﬂammasome. The investigators used a 3-dimensional
model of human normal colonic mucosa explant culture,
an ex vivo system that not only maintains the architecture of
the tissue but also contains various mucosal resident
cells that can interact to trigger an innate immune response.
They used this tissue culture model to dissect a sequence
of cellular and molecular events triggered by IFN-a. First,
they found that IFNa disturbs homeostasis in the human
normal colonic mucosa by rapidly inducing apoptosis of
entire crypts, but this response was variable among tissue
fragments fromdifferent patients because in 21%of the cases
IFN-a had no apoptotic effect. Interestingly, these observa-
tions indicated that their ex vivo model was able to recapit-
ulate the heterogeneity of cancer patients’ responses to
IFN-a–based treatment regarding intestinal disorders as a
side effect.2
This study continued by elucidating mechanisms
involved in IFN-a–induced apoptosis in the human intestinal
mucosa, considering not only the epithelium itself, but other
mucosal resident cells preserved in colonic explants and
their interactions. IFN-a induced a Th1 response, with
increased numbers of T-betþ T lymphocytes in the lamina
propria along with augmented levels of IFN-g. By using
different inhibitors of the inﬂammasome pathway in the
explant cultures, they were able to determine a sequence of
events leading to intestinal barrier disruption. Such studies
are complicated in animal models because of variables such
as routes of drug delivery, drug clearance and half-life,
confounding systemic effects of drugs, and difﬁculties in
synchronizing cellular responses in the tissue to determine
an unequivocal succession of causal events. Their data
showed the following cascade: IFN-a activates caspase-1
in epithelial and mononuclear cells that produce inter-
leukin (IL)18 and induces IFN-g secretion by T-betþ T
lymphocytes in the lamina propria, causing epithelial cell
apoptosis and subsequent intestinal barrier disruption.
The human normal colonic explant culture allowed Jarry
et al1 to investigate how IFN-a affects intestinal mucosa
homeostasis through a cross-talk between epithelial and
immune cells and describe the mechanisms involved. TheCe
EDI 5.4.0 DTD  JCMGH178 proof  23possibility of a direct effect of IFN-a in the human colonic
epithelium, however, cannot be discarded completely. The
investigation of a direct effect of cytokines on GI epithelial
cells has been neglected over the years, with investigators
instead concerned primarily with how cytokines are
produced by and interact with immune cells. One reason for
our blind spot about direct epithelial cell production of and
response to cytokines could be the lack of in vitromodels that
allows dissection of the various cellular players involved.
Recently, this issue was addressed by using another type of
3-dimensional model, the organoid culture composed
exclusively of epithelial cells. Mouse small intestinal
organoids have been used to show that IFN-g directly induces
degranulation and apoptosis of Paneth cells, which are
not affected by other cytokines studied, including IL22.3
Nevertheless, IL22 inﬂuences mouse and human small in-
testinal organoids in a different way by directly promoting
proliferation of intestinal stem cells.4 The epithelial response
to chronic inﬂammation has been assessed by exposing
mouse colonic organoids to IL1b, IL6, tumor necrosis factora,
LPS, and ﬂagellin for 60 weeks, and resulted in persistent
nuclear factor-kB activation and epithelial cell trans-
formation.5 The possibility of investigating interactions
between differentmucosal cells is an important characteristic
of the explant culture used by Jarry et al,1while questions that
require a still complex, but more isolated, epithelial-focused
system beneﬁt from organoids. Therefore, associating
both explant and organoid models can help elucidate
the molecular and cellular mechanisms involved in the
interplay between the GI epithelium and immune cells, by
determining the precise roles of intermediate cytokines in the
maintenance and disturbance of tissue homeostasis.
Establishing systems wherein human primary cells can
be cultured in varying complexity from pure epithelial
organoids to mixed cultures of several tissue types is exciting
because we now can begin to determine the role of genetic
variability in cytokine response. Such variability among
human beings might help explain why patients respond
differently to pathogens and to drugs, which eventually
should allow us to better understand how to target therapy
in a more precise way (ie, precision medicine) Q.
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